ModernMedicine Resource Center More Topics

Hot Topics in Prostate Cancer

Biennial vs. annual prostate biopsies: What the data showAmong men undergoing active surveillance for low-risk prostate cancer, biennial biopsies appear to be an acceptable alternative to annual biopsies.
Prostate Ca test linked to reduction in biopsiesPatients with non-suspicious digital rectal exam findings and total PSA in the 4.0- to 10.0-ng/mL range are far less likely to be biopsied if they’ve undergone Prostate Health Index (phi) testing than if they don’t.
PSA screening: What do you tell primary care docs?We asked several urologists about whether they advocate for PSA screening to primary care physicians in their area.
Pair of genes may predict prostate cancer metastasisOverexpression of a specific pair of genes might provide early warning of prostate cancer patients’ likelihood of progressing to metastatic disease.
Why you need to better counsel PCa patients on sexual functionThere’s a troubling disconnect between low-risk prostate cancer patients’ desire to preserve sexual function and the treatment choices they and their doctors often make.
Immune content linked to aggressive PCa outcomesThe level of immune response in prostate cancer may predict a patient’s response to radiation therapy, risk of disease recurrence, and survival outcomes, according to results of a recent analysis of prostate tumors.
Antiandrogen’s role may extend to non-metastatic CRPCTop-line results from a large phase III trial support a potential role for enzalutamide (XTANDI) as treatment for non-metastatic castration-resistant prostate cancer.
Robotic vs. open RP: Better EF recovery seen with robotRobot-assisted radical prostatectomy was associated with earlier and increased rate of recovery of erectile function when compared to radical retropubic prostatectomy and a slightly higher but acceptable rate of positive surgical margins, according to a study published online in European Urology (Sept. 4, 2017).
Prostate Ca study reveals more evidence of racial disparityResults of a study examining receipt of definitive therapy for intermediate/high-risk localized prostate cancer provide further evidence of racial disparity in prostate cancer favoring Caucasian men over African-American men.
Quality initiative could reduce unnecessary PCa bone scansOne gentle “nudge” may be all it takes to start reducing the number of unnecessary bone scans ordered for asymptomatic men with low-risk prostate cancer, results of a recent quality improvement intervention suggest.